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Retinal vascular diseases are important causes of vision loss. A
detailed evaluation of the vascular abnormalities facilitates diagno-
sis and treatment in these diseases. Optical coherence tomography
(OCT) angiography using the highly efficient split-spectrum ampli-
tude decorrelation angiography algorithm offers an alternative to
conventional dye-based retinal angiography. OCT angiography has
several advantages, including 3D visualization of retinal and cho-
roidal circulations (including the choriocapillaris) and avoidance of
dye injection-related complications. Results from six illustrative
cases are reported. In diabetic retinopathy, OCT angiography can
detect neovascularization and quantify ischemia. In age-related
macular degeneration, choroidal neovascularization can be ob-
served without the obscuration of details caused by dye leakage
in conventional angiography. Choriocapillaris dysfunction can be
detected in the nonneovascular form of the disease, furthering our
understanding of pathogenesis. In choroideremia, OCT’s ability to
show choroidal and retinal vascular dysfunction separately may be
valuable in predicting progression and assessing treatment re-
sponse. OCT angiography shows promise as a noninvasive alter-
native to dye-based angiography for highly detailed, in vivo, 3D,
quantitative evaluation of retinal vascular abnormalities.
optical coherence tomography angiography | ophthalmic imaging |
ocular circulation
Optical coherence tomography (OCT) has become the mostcommonly used imaging modality in ophthalmology. It pro-
vides cross-sectional and 3D imaging of the retina and optic
nerve head with micrometer-scale depth resolution. Structural
OCT enhances the clinician’s ability to detect and monitor fluid
exudation associated with retinal vascular diseases. Whereas
anatomical alterations that impact vision are readily visible,
structural OCT has a limited ability to image the retinal or
choroidal vasculatures. Furthermore, it is unable to directly de-
tect capillary dropout or pathologic new vessel growth (neo-
vascularization) that are the major vascular changes associated
with two of the leading causes of blindness, age-related macular
degeneration (AMD) and diabetic retinopathy (1). To visualize
these changes, traditional i.v. contrast dye-based angiography
techniques are currently used.
Fluorescein dye is primarily used to visualize the retinal vas-
culature. A separate dye, indocyanine green (ICG), is necessary
to evaluate the choroidal vasculature. Both fluorescein angiog-
raphy (FA) and ICG angiography require i.v. injection, which is
time consuming, and which can cause nausea, vomiting, and,
rarely, anaphylaxis (2). Dye leakage or staining provides infor-
mation regarding vascular incompetence (e.g., from abnormal
capillary growth), but it also obscures the image and blurs the
boundaries of neovascularization. Additionally, conventional an-
giography is 2D, which makes it difficult to distinguish vascular
abnormalities within different layers. Therefore, it is desirable to
develop a no-injection, dye-free method for 3D visualization of
ocular circulation.
In recent years, several OCT angiography methods have been
developed to detect changes in the OCT signal caused by flowing
red blood cells in blood vessels. Initially, Doppler OCT angiog-
raphy methods were investigated for the visualization and mea-
surement of blood flow (3–8). Because Doppler OCT is only
sensitive to motion parallel to the OCT probe beam, it is limited
in its ability to image retinal and choroidal circulations, which
are predominantly perpendicular to the OCT beam. More recent
approaches, based on detecting variation in the speckle pattern
over time, are sensitive to both transverse and axial flow. Several
types of speckle-based techniques have been described, including
amplitude-based (9–11), phase-based (12), or a combination of
both amplitude and phase (13) variance methods.
We developed an amplitude-based method called split-spectrum
amplitude-decorrelation angiography (SSADA). The SSADA al-
gorithm detects motion in the blood vessel lumen by measuring the
variation in reflected OCT signal amplitude between consecutive
cross-sectional scans. The novelty of SSADA lies in how the OCT
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signal is processed to enhance flow detection and reject axial bulk
motion noise. Compared with the full-spectrum amplitude method,
SSADA using fourfold spectral splits improved the signal-to-noise
ratio (SNR) by a factor of two, which is equivalent to reducing the
scan time by a factor of four (14). More recent SSADA imple-
mentations use even more than a fourfold split to further enhance
the SNR of flow detection. This highly efficient algorithm gener-
ates high-quality angiograms of both the retina and choroid. The
angiograms have capillary-level detail and can be obtained with
currently available commercial OCT systems.
This article uses six illustrative cases and highlights the various
types of vascular pathologies that can be detected and measured
using SSADA and an OCT angiography system of visualization.
Additionally, we describe techniques designed to help clinicians
rapidly interpret OCT angiograms and to easily identify patho-
logical vascular features. These techniques include (i) separation
of the 3D angiogram into individual vascular beds via segmenta-
tion algorithms, (ii) presentation of en face OCT angiograms,
analogous to traditional angiography, (iii) creation of cross-sec-
tional structural OCT images with superimposed OCT angiograms
to help correlate anatomical alterations with vascular abnormali-
ties, and (iv) quantification of neovascularization and capillary
dropout in both the retinal and choroidal circulation.
Results
Retinal and Choroidal Microcirculation in Normal Subjects. The ret-
ina and choroid are two distinct vascular beds. The 3D nature of
OCT angiography allows separate visualizations of these two
circulations from the same volumetric scan. In healthy eyes,
retinal circulation is located between the internal limiting mem-
brane (ILM) and the outer plexiform layer (OPL), whereas the
choroidal circulation is beneath Bruch’s membrane (BM). The
vitreous (anterior to the ILM) and outer retina (between OPL
and Bruch’s membrane) are avascular in normal eyes. One way
to present OCT angiography is to use different colors, each
representing different vascular beds, superimposed on gray-
scale, cross-sectional, structural OCT images (Fig. 1A). Using
this technique, both blood flow and retinal structural information
are presented on a single image.
En face presentation of OCT angiography is comparable to
the traditional view of dye-based angiography and is necessary
for clinicians to identify vascular patterns. Segmented en face
OCT angiograms can be displayed as individual retinal and
choroidal circulations (Fig. 1 C and E). In healthy eyes, the vit-
reous and outer retinal layers are colored black (Fig. 1 B and D),
representing the absence of flow.
In vivo imaging of the choroid is limited with current imaging
modalities (15). High-quality OCT angiograms of the chorioca-
pillaris can be obtained by segmenting a thin slice (10 μm) of the
inner choroid below Bruch’s membrane (Fig. 1E). The larger and
deeper choroidal vessels are more difficult to visualize with
SSADA-based OCT angiography because choriocapillaris flow
causes a flow projection artifact in the deeper layers. Selective
removal of this artifact is impossible, given the near confluent
nature of the choriocapillaris. Another reason is that high flow in
the larger choroidal vessels reduces the OCT signal due to in-
terference fringe washout. However, visualization of the larger,
deeper choroidal vessels is possible using an inverse reflectance
display scale (Fig. 1F). This en face choroidal image is achieved by
taking advantage of the OCT signal void produced by interference
fringe washout in regions of very high flow velocity (16).
Retinal Neovascularization and Capillary Dropout in Diabetic Retinopathy.
Diabetic retinopathy is a microangiopathy characterized by
capillary occlusion, hyperpermeability, and neovasculariza-
tion (17). These pathophysiologic changes cause proliferative
diabetic retinopathy and macular edema, which are respon-
sible for most of the vision loss associated with this disease
(18). Assessment of the microvascular changes with FA has
been validated as a way to classify disease severity and predict
progression (19).
Like FA, OCT angiography can visualize areas of low capillary
perfusion or dropout. Fig. 2 compares en face retinal OCT an-
giograms from a normal subject to those from a patient with
nonproliferative diabetic retinopathy (NPDR). The central 0.6-mm
Fig. 1. Optical coherence tomography (OCT) angiography (3 × 3 mm) of a healthy human eye, acquired using a 70-kHz spectral OCT system with an 840-nm
center wavelength. (A) Cross-sectional composite OCT angiogram. Depth layer segmentation lines are shown in green. BM, Bruch’s membrane; ILM, internal
limiting membrane; OPL, outer plexiform layer. Flow signals are color coded by depth: purple, anterior to the OPL; red, posterior to BM. (B) En face OCT
angiogram above the ILM shows the normal, avascular vitreous. (C) En face OCT angiogram between the ILM and OPL shows the normal retinal vasculature.
(D) En face OCT angiogram between the OPL and BM shows the normal, avascular outer retina. (E) En face OCT angiogram of the inner 10 μm of the choroid
shows dense, relatively even flow throughout the central macula (3 × 3 mm). (F) En face OCT structural image with an inverse gray scale shows the deeper
choroid with medium- and large-sized vessels.
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circle encompasses the normal foveal avascular zone (FAZ), and
areas of capillary loss are represented by dark areas elsewhere in
the macula. No dark areas are present outside of the FAZ in the
normal subject (Fig. 2 B1, C1, and D1), whereas the patient with
NPDR has enlargement of the normal FAZ and extensive loss of
the macular capillary bed (Fig. 2B2). Nonperfusion areas on FA
correspond to those on OCT angiography (Fig. 2 B2 and C2).
SSADA also enables the quantitative evaluation of local cir-
culation by determining the flow index and vessel density in areas
of interest, such as the parafoveal and perifoveal areas that
correspond respectively to the 3-mm and 6-mm early treatment
diabetic retinopathy study (ETDRS) macular fields (as demon-
strated in Fig. 2) (19). Nonperfusion maps may be created (Fig. 2
D1 and D2) that allows for the area of nonperfusion to be cal-
culated and compared between sequential angiograms.
The development of retinal neovascularization (RNV) sig-
nifies progression to the proliferative phase of the disease.
Recognition of this change is important because it may guide
panretinal photocoagulation and other treatments to reduce the
risk of vision loss due to RNV (20). Because OCT angiograms
can be segmented by anatomic planes such as the ILM, it can be
particularly effective in distinguishing between intraretinal mi-
crovascular abnormalities, which occur in the same plane as the
retinal blood vessels, and early RNV, which develops anterior to
the retinal vessels and may extend into the vitreous cavity (Fig.
3). The extent and viability of RNV can also be quantified on
OCT angiography by vessel area and flow index. Thus, compared
with FA, OCT angiography has the advantages of 3D localization
and quantification.
Choroidal Neovascularization in Age-Related Macular Degeneration.
Choroidal neovascularization (CNV), the hallmark pathologic
feature of neovascular AMD, consists of abnormal blood vessels
that grow from the choriocapillaris and penetrate through
Bruch’s membrane into the subretinal pigment epithelium (sub-
RPE) space and subretinal space. Subsequent exudation and
hemorrhage damage retinal tissue, resulting in vision loss (21).
FA is the gold standard for CNV diagnosis (22); however, it is
limited by its 2D nature. In addition, blocked fluorescence from
the RPE or hemorrhage (if present) reduces visibility of the
CNV beneath the RPE, as well as visualization of the choroid
(23). OCT angiography has the capability to generate 3D an-
giograms of the retina, choroid, and CNV that is otherwise ob-
scured in FA by RPE blockage or hemorrhage.
In an example of neovascular AMD (Fig. 4A), the late FA
image (Fig. 4B) shows a stippled hyperfluoresence leakage pat-
tern, indicating the presence of an occult CNV. The outer retina
is devoid of blood flow in healthy eyes, and the flow detected in
this area is associated with the presence of CNV. Color-coded
composite en face OCT angiography allows for 3D representa-
tion of retinal flow, outer retinal flow, and choroidal flow on a
single 2D image. In this case, the CNV is highlighted in yellow,
and the extent and microvascular structure (Fig. 4C) is better
defined compared with traditional FA image (Fig. 4B). The
cross-sectional structural OCT image with a color-coded OCT
angiogram overlay (Fig. 4D) demonstrates the depth of the
CNV, in this case beneath the RPE, as well as the presence of
fluid exudation and disruption of outer retinal anatomy.
This case illustrates the capability of OCT angiography to
assess the morphology, extent, and depth of CNV in AMD. We
have demonstrated that OCT angiography can be used to classify
CNV as type I (between the RPE and Bruch’s membrane, Fig.
4D), type II (above the RPE), type III (in the inner retina), or a
combined type (24). OCT angiography can furthermore provide
Fig. 2. Quantification of inner retinal blood flows in normal control (A1–D1) and nonproliferative diabetic retinopathy (NPDR) with macular edema (A2–D2).
OCT angiography was acquired using a 70-kHz spectral OCT system with a center wavelength of 840 nm. White dashed circle indicates normal foveal avascular
zone (FAZ, 0.6 mm diameter white dashed circle). Area between white and blue dashed circles indicates parafoveal zone. Area between blue and green
dashed circles indicates perifoveal zone. First column (A1 and A2) indicates fundus photo (A1) and fluorescein angiography (A2). Second column (B1 and B2)
indicates en face 3 × 3 mm OCT angiograms. Enlargement of the FAZ is present in the parafoveal region for NPDR (B2). Parafoveal and perifoveal retinal flow
indexes (vessel densities) are shown on en face 6 × 6 mm OCT angiograms (C1 and C2). Nonperfusion areas (blue) are shown of 6 × 6 mm OCT angiograms (D1
and D2). The normal subject had a FAZ of 0.30 mm2, whereas the NPDR case showed an enlarged FAZ and scattered areas of macular nonperfusion totaling
7.07 mm2. Decorrelation (shown by the scale bar) as calculated by the SSADA algorithm measures fluctuation in the backscattered OCT signal amplitude
(intensity). It is linear to blood flow velocity up to a saturation limit after which it reaches a maximum value. The linear range is approximately within the
limits of capillary flow velocity.
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quantitative data regarding CNV flow and area. These capabil-
ities may prove to be valuable in the assessment of disease se-
verity and monitoring of the effectiveness of treatment. It is
likely that, in many cases, CNV growth through Bruch’s mem-
brane occurs before the onset of exudation and visual symptoms.
Whereas visual acuity at presentation is strongly predictive of the
posttreatment outcome (25), OCT angiography may enable the
detection of CNV before the development of symptoms or de-
tectable changes with structural OCT or FA. Because it is a safe,
noninvasive, and rapid imaging technique, at-risk patients may
benefit from OCT angiography screening.
Choriocapillaris Loss in Age-Related Macular Degeneration. The
choriocapillaris has been implicated in the progression of AMD.
In advanced nonneovascular AMD, geographic atrophy (GA) is
associated with loss of photoreceptors, RPE, and the chorioca-
pillaris. Whether the RPE or choriocapillaris alterations are the
primary event in pathogenesis has been a matter of debate (26).
Histologic studies have described choriocapillaris dysfunction in
the intermediate stage of AMD, before development of GA or
choroidal neovascularization (27, 28). Whereas efforts have been
made to assess the choriocapillaris in vivo (29), its small size,
high density, and high permeability have made it difficult for
conventional imaging modalities, including FA and ICG, to
provide meaningful assessment. By segmenting a layer extending
10 μm posterior to Bruch’s membrane, OCT angiography pro-
vides qualitative and quantitative evaluation of the chorioca-
pillaris, which may be valuable in understanding its role in AMD.
OCT angiography has utility in elucidating the state of the
choriocapillaris in GA (Fig. 5). In a patient with perifoveal GA,
the fundus photograph (Fig. 5A) and autofluorescence image
(Fig. 5B) show the affected region. The drusen–RPE complex
thickness map (the axial distance from the apex of the drusen
and the RPE layer to BM, Fig. 5C) shows an area of RPE loss
corresponding to the clinically evident GA. The choriocapillaris
flow is absent in most of the area correlating to clinical GA (Fig. 5
E and F). Prior histopathological findings (27) showed that viable
choriocapillaris can exist in areas of GA, but highly constricted.
OCT angiography is based on flow detection; therefore, con-
stricted choriocapillaris with little or no flow may appear absent.
In some areas near the border of the GA with RPE loss, intact
choriocapillaris flow is present (Fig. 5 G and H). In this area of
preserved choriocapillaris and slightly beyond it, the outer nuclear
layer is also preserved; however, in most of the GA area, the outer
nuclear layer, photoreceptors, and RPE are absent.
Choriocapillaris Loss in Choroideremia. Pathology of the chorioca-
pillaris has been implicated in many disease processes apart from
AMD, including those with genetic, inflammatory, and infectious
etiologies. Choroideremia is an X-linked recessive chorioretinal
dystrophy associated with mutation of the CHM gene. This gene
encodes the Rab escort protein 1 (REP-1) and is characterized by
significant atrophy of the RPE and choriocapillaris with photore-
ceptor loss (30). Affected patients typically experience night
blindness in their first or second decade, followed by constriction of
the peripheral visual fields until central vision is lost. Patients with
choroideremia often demonstrate retinal vessels of normal caliber
until late in the disease, suggesting a relatively greater loss of
choroidal blood flow (30). Spectral-domain OCT studies of
Fig. 3. Proliferative diabetic retinopathy (PDR) case imaged using a 100-kHz
swept-source OCT system with a center wavelength of 1,050 nm. (A) Con-
focal scanning laser ophthalmoscope (cSLO) shows retinal neovascularization
at the optic disk (NVD) and attenuated retinal vessels. (B) FA showing NVD
and peripapillary capillary dropout. The green squares in A and B outline the
3 × 3 mm area shown on the OCT angiogram below. (C) En face OCT angi-
ography showing NVD and areas of capillary dropout that correspond to FA
(NV is shown in light red gold; normal retinal vessels are in purple). The area
of NVD was 0.47 mm2. The vitreous flow index was 0.022. (D) Cross-sectional
composite OCT angiogram showing NVD above the inner limiting mem-
brane (red/gold).
Fig. 4. Type I CNV case imaged by a 100-kHz swept-source OCT system with
a center wavelength of 1,050 nm. The CNV is identified by OCT angiography
(3 × 3 mm), but it is ill defined by fluorescein angiography (FA). (A) Fundus
photograph. The black square outlines the areas shown on the angiograms.
(B) Late stage fluorescein angiograph showing an occult CNV. (C) Composite
en face color-coded OCT angiogram with CNV flow highlighted in yellow.
The CNV area was 0.96 mm2 and the outer retina flow index was 0.012. The
yellow dashed line indicates the position of the OCT cross-section. (D) Cross-
sectional color OCT angiogram. Both composite en face (C) and cross-sec-
tional color OCT angiograms (D) show inner retinal flow in purple, outer
retinal flow (CNV) in yellow, and choroidal flow in red. The CNV is pre-
dominantly under the RPE.
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patients with choroideremia show photoreceptor rosettes, sug-
gesting loss of RPE before that of photoreceptors. However, the
temporal relationship of RPE loss versus choriocapillaris loss
is unknown.
OCT angiography with SSADA may aid in understanding the
disease pathogenesis and inform the debate on whether de-
generation occurs first in the choriocapillaris, RPE, or photo-
receptors. En face OCT angiography has the ability to map both
retinal and choroidal perfusion down to the capillary level. In the
three subjects with choroideremia, OCT angiography (Fig. 6)
showed that the choriocapillaris nonperfusion area was more
extensive than the retinal nonperfusion in all cases. The area of
RPE loss was even more extensive than choriocapillaris non-
perfusion. These patterns suggest that RPE loss might be the
primary event, with subsequent choroidal perfusion loss follow-
ing more closely than retinal perfusion loss. With the recent
initiation of gene therapy trials (31), the ability to quantify and
map both choroidal and retinal circulations may prove valuable
in assessing disease severity and response to treatment.
Discussion
The cases presented in this article show the potential clinical
applications of OCT angiography for noninvasive vascular im-
aging in the eye. Although clinical studies using OCT angiogra-
phy have investigated polypoidal choroidal vasculopathy (32),
macular degeneration (33, 34), diabetic retinopathy (35), and
macular telangiectasia type 2 (36, 37), they were descriptive in
nature. In this study, a comprehensive OCT angiography system
was demonstrated that includes scanning, flow detection, seg-
mentation, display, and quantification. There are several im-
portant contributions in this report. First, OCT angiography with
SSADA is able to capture a large 6 × 6 mm view of the macula
with adequate resolution using a commercially available OCT
system. Second, the multicolor display system shows multiple
circulations in the same image panel so that the location of pa-
thologies can be located in relation to the retinal vasculature
with minimal interference from flow projection artifacts. Third,
quantification of RNV and quantification of the area of capillary
dropout in the retinal circulation and choriocapillaris are also
shown in vivo for the first time to our knowledge.
OCT angiography differs from FA, in which ocular pathology
is typically highlighted by leakage and staining. On OCT angi-
ography, ocular pathologies are identified by the abnormal
presence of flow in layers that usually lack blood vessels or the
absence of flow in normally vascular layers. Because dye leakage
and staining do not occur in OCT angiography, the boundaries,
and therefore areas, of capillary dropout and neovascularization
can be measured without these complications. OCT angiography
has several other compelling characteristics that make it a prom-
ising modality for clinical use. OCT angiography using SSADA
can be acquired in a few seconds, a dramatic improvement com-
pared with several minutes for FA. Its 3D nature allows separate
evaluation of abnormalities in retinal and choroidal circulations.
Additionally, quantitative information, such as vessel density, flow
index, and nonperfusion areas, can now be obtained. OCT angi-
ography might be useful in assessing the response of CNV to
antiangiogenic treatment by quantifying the size and flow index of
CNV before and after therapy. Furthermore, the scan pattern and
SSADA processing can be implemented on spectral-domain or
swept-source OCT systems without any special hardware modifi-
cation, provided that imaging speeds are sufficient; i.e., ≥70 kHz is
required to provide 6 × 6 mm angiograms with capillary details
within a reasonable scan time (≤3 s).
OCT angiography has several limitations and requirements.
First, projection artifacts are observed on the cross-sectional
angiograms. These artifacts are due to fluctuating shadows cast
by flowing blood in large inner retinal vessels that cause variation
in the OCT signal from deeper layers. The projection artifact
Fig. 5. Geographic atrophy case imaged by a 100-kHz swept-source OCT system with a center wavelength of 1,050 nm. (A) Fundus photograph showing the
area of geographic atrophy (GA) adjacent to the foveal center. (B) An autofluorescence image sharply outlines the area of absent RPE and is surrounded by a
halo of hyperautofluorescence. The green squares in A and B outline the area shown in C–F. (C) A drusen–RPE complex thickness map shows the area of RPE
thinning (the dark area nasally). (D) An en face OCT structural image on an inverse gray scale of the deeper choroid reveals medium- and large-sized vessels.
(E) An en face OCT angiogram (3 × 3 mm) of the choriocapillaris shows dramatically decreased, but not absent, choriocapillaris flow in the area of GA. (F) The
light blue color represents the choriocapillaris nonperfusion area (2.75 mm2). (G and H) Cross-sectional composite OCT angiograms show the absence of
choriocapillaris flow in most of the area of GA, but the flow at the edge of the atrophy is spared (shown by the green arrows in the magnified views).
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from the retinal circulation can be easily removed from the en
face views of deeper layers because the retinal vasculature is
relatively sparse. However, the choriocapillaris is nearly conflu-
ent, and its shadow often obscures OCT angiography visualiza-
tion of deeper choroidal vessels. Second, the flow signal fadeout
in large vessels with very fast blood flow can induce fringe
washout of OCT signals (16). This means that central retinal
vessels in the disk and large vessels in the deep choroid cannot be
visualized using SSADA. However, we can use an inverted signal
scale to take advantage of fringe washout to visualize deep
choroidal vessels. Third, decorrelation (flow signal) is linearly
related to velocity over a limited range. A higher decorrelation
value thus implies higher velocity flow. This range is dependent
on the time scale of the SSADA measurement. With a 70-kHz
spectral OCT system and 200+ A-scans per cross-sectional
B-scan, SSADA should be sensitive to the normal capillary flow
speeds, which have been estimated at between 0.4 and 3 mm/s
(38, 39). If blood flow is extremely slow in pathological condi-
tions, the decorrelation values may be below noise background,
in which case flow would not be detected by OCT angiography.
In larger vessels with higher velocities, the SSADA signal rea-
ches a maximum value (saturates). This suggests that the angi-
ography-based flow index, at current scan speeds, is a mixed
measure of vascular density of both large and small vessels plus a
Fig. 6. Choroideremia case imaged by a 100-kHz swept-source OCT system with a center wavelength of 1,050 nm. The large-field en face OCT angiograms
(∼3 × 8.5 mm) were produced by stitching together three 3 × 3 mm scans. (A) OCT angiography of inner retinal blood flow. (B) OCT angiography with
quantification of inner retinal blood flow demonstrating patchy areas of nonperfusion (blue) in the extrafoveal macula. The total nonperfusion area of the
inner retina was 7.65 mm2. (C) OCT angiography of the choroidal blood flow, including choriocapillaris and deep choroid. It should be noted that OCT
angiography is able to image deeper choroidal vessels in this case due to the relative absence of the overlying choriocapillaris and RPE. (D) OCT angiography
of the choroidal blood flow with quantification of the choriocapillaris nonperfusion area (purple), which was 12.11 mm2 (47.5% of image area). (E) An
autofluorescence image outlines the area of existing RPE (hyperautofluorescent area).
E2400 | www.pnas.org/cgi/doi/10.1073/pnas.1500185112 Jia et al.
component of capillary flow velocity. Fourth, unlike FA, OCT
angiography cannot visualize dye leakage. However, the visuali-
zation of intraretinal and subretinal fluid accumulation on
structural OCT may provide information associated with fluid
leakage (40), whereas CNV activity may be evaluated by assess-
ing the presence or characteristics of its perfusion (24). Fifth, the
scan area is relatively small (3 × 3–6 × 6 mm). Larger area an-
giograms can be achieved, but it would require higher speed
OCT systems that are not yet commercially available (41). Lastly,
because OCT angiography identifies depth resolve pathology,
practical clinical applications require automated image process-
ing software that accurately delineates tissue layers.
In summary, OCT angiography can provide safe and repeatable
(42) high-resolution images of retinal and choroidal circulations, in
addition to structural OCT information. Its ability to noninvasively
visualize neovascularization and nonperfusion unaffected by leak-
age and staining offers advantages over dye-based angiography
methods. The ability to quantify perfusion and separately visualize
retinal and choroidal vasculature makes it uniquely suited for a
variety of research and clinical applications.
Methods
Human Subjects Imaging. Study subjects were enrolled after informed consent
in accordance with an Institutional Review Board/Ethics Committee approved
protocol at Oregon Health & Science University and at the Massachusetts
Institute of Technology in compliance with the Declaration of Helsinki.
Healthy participants or patients with a diagnosis of retinal disease (diabetic
retinopathy/AMD/choroideremia) were selected from the Retina Division of
the Casey Eye Institute for their clear media and ability to fixate. In total, 15
healthy subjects, 14 with diabetic retinopathy, 26 with AMD, and 3 with
choroideremia were enrolled. To better demonstrate the potential clinical
application of this OCT methodology, six cases with characteristic patho-
logical and clinical features were selected for this article.
Color fundus and optic disk photographs were acquired with Zeiss fundus
cameras (FF3 for Figs. 2A1 and 4A and FF450 for Fig. 5; Carl Zeiss Meditec)
and the Optos 200Tx confocal scanning laser ophthalmoscope (cSLO) (Fig.
3A; Optos PLC). For fluorescein angiography, 10% sodium fluorescein in
water (500 mg/5 mL) was injected i.v. using a 23- or 25-gauge needle, fol-
lowed by a flush of normal saline. Fluorescein angiography was performed
using either the Optos 200Tx cSLO (Figs. 2A2 and 3B) or the Spectralis HRA+
OCT cSLO (Fig. 4B; Heidelberg Engineering). For both cSLO devices, a 488-nm
wavelength laser excited the fluorescein, and a barrier filter at 500 nm
separated the excitation and emission light. The fluorescein autofluores-
cence image in Figs. 5 and 6 was also acquired using the Spectralis HRA+OCT
cSLO. These procedures, imaging systems, and contrast dyes are approved by
the Food and Drug Administration.
OCT Systems. TwoOCT systems were used in this study. The first was a custom-
built swept-source OCT instrument (14, 24, 42, 43). The device operated at an
axial scan rate of 100 kHz using a swept-source cavity laser operating at
∼1,050 nm with a sweep range of 100 nm. The instrument has a 5.3-μm axial
resolution and 18-μm lateral resolution with an imaging range of 2.9 mm in
tissue. The ocular light exposure was 1.9 mW, which was within the Amer-
ican National Standards Institute safety limit (44). The second OCT system
was a commercial spectral domain OCT instrument (RTVue-XR; Optovue)
(36). The center wavelength was ∼840 nm with a full-width half-maximum
bandwidth of 45 nm and an axial scan rate of 70 kHz.
OCT Imaging. A 3 × 3 or 6 × 6 mm scanning area was used for OCT angi-
ography. In the fast transverse scanning direction, 200 axial scans were
sampled to obtain a single B-scan. Multiple repeated B-scans (eight for the
swept-source OCT and five for the spectral OCT), were captured at a fixed
position before proceeding to the next sampling location. A total of 200
locations along a 3- or 6-mm distance in the slow transverse direction were
sampled to form a 3D data cube. For the swept-source system, with a B-scan
frame rate of 455 frames per second, the 1,600 B-scans in each scan were
acquired in ∼3.5 s. Four volumetric raster scans, including two horizontal
priority fast transverse (x-fast) scans and two vertical priority fast transverse
(y-fast) scans, were obtained consecutively in one session. For the spectral
domain OCT system, with a B-scan frame rate of 320 frames per second, the
1,000 B-scans in each scan were acquired in ∼3.1 s. Two volumetric raster
scans including one x-fast scan and one y-fast scan were obtained.
SSADA Processing. The SSADA algorithm was used to distinguish blood flow
from static tissue as described in detail in a previous publication (14). By
calculating the decorrelation of the signal amplitude from consecutive
B-scans, contrast between static and nonstatic tissue is created that enables
visualization of blood flow. Decorrelation is a mathematical function that
quantifies variation without being affected by the average signal strength,
as long as the signal is strong enough to predominate over optical and/or
electronic noise. Specifically, the algorithm splits the OCT image into dif-
ferent spectral bands, thus increasing the number of usable image frames. In
the optimized SSADA technique, the OCT signal is first split into 11 spectral
bands to obtain 11 low axial resolution images instead of a single image
frame with high axial resolution. Each new frame has a lower axial resolu-
tion that is less susceptible to axial eye motion caused by retrobulbar pul-
sation. This lower resolution also translates to a wider coherence gate over
which reflected signal from a moving particle such as a blood cell can in-
terfere with adjacent structures, thereby increasing speckle contrast. In
addition, each spectral band contains a different speckle pattern and in-
dependent information on flow. When amplitude decorrelation images
from multiple spectral bands are combined, the flow signal is increased. By
enhancing the flow signal and suppressing bulk motion noise, SSADA im-
proves the signal-to-noise ratio of flow detection by at least a factor of two
(14). Motion artifacts were further corrected and the flow signal increased
by applying an image registration algorithm that registered orthogonal
raster-scanned volumes (45).
OCT Angiogram Visualization and Quantification. To enhance visualization, the
3D angiogram was separately projected as en face views in five layers: vitreous,
inner retina, outer retina, choriocapillaris, and deep choroid (Fig. 1). The sep-
arated en face OCT angiography images were presented in a sepia color scale.
A composite view was created, where each layer was assigned a different color.
The color-coded angiogram can be superimposed on a gray-scale, cross-sec-
tional, structural OCT image to demonstrate blood flow and structural in-
formation simultaneously. Flow projection artifacts are a common problem for
existing OCT angiography techniques (3–13). To better distinguish and interpret
the blood flow within different layers, a negative filter was used to mask
projection artifacts from the larger caliber retinal vessels (24).
To quantify the blood flow within the regions of interest, the flow index,
vessel density, and neovascularization areawere determined from the en face
maximum projection angiogram. The flow index was calculated as the av-
erage decorrelation value (which is correlated with flow velocity) in the
selected region, and the vessel density was calculated as the percentage area
occupied by vessels and microvasculature in the selected region. For scans of
themacula, flow index and vessel density can be routinely determined for the
parafovea and/or perifovea. The parafovea is defined to be an annular region
with an inner diameter of 0.6 mm and outer diameter of 2.5 mm centered on
the FAZ. The perifovea is defined to be the annular region extending from the
edge of the parafovea to an outer diameter of 5.5mm. For a 3 × 3mm scan, only
the parafovea values can be determined. Examples from macular angiograms
are shown in Fig. 2 C1 and C2. The vitreous or outer retinal flow index can be
used to indicate the RNV or CNV flow within the scanned area (3 × 3 or 6 × 6
mm) of the vitreous or outer retina. The retinal or choroidal neovascularization
area was the area occupied by vessels in the vitreous or outer retina. To identify
and quantify the capillary dropout of the inner retina or choriocapillaris, the
nonperfusion map was created by identifying decorrelation values lower than a
set cutoff point, typically 2.33 SD below the mean according to the normal
distribution. Morphologic operations were then used to remove areas below a
certain size to reduce noise. The remaining areas were then summed and
converted from pixels to metric units.
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